...Bartosz Malisiewicz; Carla Murer; Jana Pachlopnik Schmid; Lars E. French; Peter Schmid-Grendelmeier; Alexander A. Navarini Psoriasis vulgaris Eosinophilia Tumour necrosis factor α Adalimumab Etanercept 2 2 2012 © 2010 S. Karger AG, Basel 2012 Copyright / Drug Dosage...

.... Linear IgA disease Chronic bullous disease of childhood Basement membrane zone Target antigens Split skin Cylindroma Immunoblotting Human leucocyte antigen Tumour necrosis factor α Dermatology 1994;189(suppl 1):52 56 F. Wojnarowska Alien P. Coilierh Department of Dermatology, Churchill...

...F. Ameglio; C. Bonifati; M. Pietravalle; M. Fazio Background: Involvement of various cytokines in psoriasis pathomechanisms has previously been reported. Objective: To better define the relationship between the disease severity and interleukin-6 and tumour necrosis factor α skin levels, these two...

... to in the content or advertisements. Alopecia areata Adalimumab Tumour necrosis factor α Tumour necrosis factor inhibitors Side effects In recent years, a growing number of biological agents have been introduced for the treatment of various auto-immune, allergic, neoplastic and other diseases...

... of the joint condition. Two weekly injections of 25 mg of the tumour necrosis factor α inhibitor etanercept led to a rapid improvement of his psoriatic arthritis, as well as regression of the pustular eruption, while residual erythema was still present. The clinical response was reflected by an increase...

... Tumour necrosis factor α Interleukin 1 Adhesion molecules Clonal T cell proliferation Cutaneous polyarteritis nodosa (PAN), a chronic disease, is a necrotizing vasculitis of the small and medium-sized vessels of unknown aetiologies. The skin lesions, like erythematous papules and nodules...